日清食品(01475.HK):控股股東中國分部首9月經營利潤升32.2%至40.17億日元
格隆匯2月3日丨日清食品(01475.HK)公佈,截至2020年12月31日止9個月,控股股東日本日清中國業務分部收入為353.32億日元,同比增長13.4%;經營溢利為40.17億日元,同比增長32.2%。
在中國,高增值面市場持續在中國大陸擴張。集團積極擴展其地域銷售面積並強化其合味道品牌。此外,2019冠狀病毒病爆發後,宅經濟令即食麪的需求上漲。在此環境下,有賴於合味道品牌及出前一丁品牌在中國大陸及香港的強勁銷售量表現,銷售額按年增加。溢利按年增加乃由於中國大陸及香港銷售量增加,以及來自銷售量增加相關的成本降低。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.